Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0AV1T
|
|||
| Former ID |
DNC013701
|
|||
| Drug Name |
N-(2-iodethyl)arachidonylamide
|
|||
| Synonyms |
N-(2-iodethyl)arachidonylamide; CHEMBL509376
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H36INO
|
|||
| Canonical SMILES |
CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCI
|
|||
| InChI |
1S/C22H36INO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22(25)24-21-20-23/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-21H2,1H3,(H,24,25)/b7-6-,10-9-,13-12-,16-15-
|
|||
| InChIKey |
KOHVJRAXSGONGW-DOFZRALJSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Radiosynthesis, in vitro and in vivo evaluation of 123I-labeled anandamide analogues for mapping brain FAAH. Bioorg Med Chem. 2009 Jan 1;17(1):49-56. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.